Less invasive ventricular reconstruction for ischaemic heart failure
Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic
Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie, práce podpořená grantem
PubMed
31797492
DOI
10.1002/ejhf.1669
Knihovny.cz E-zdroje
- Klíčová slova
- Device intervention, Heart failure, Myocardial infarction, Ventricular remodelling, Volume reduction,
- MeSH
- design vybavení MeSH
- funkce levé komory srdeční fyziologie MeSH
- ischemická choroba srdeční komplikace patofyziologie MeSH
- kardiochirurgické výkony přístrojové vybavení MeSH
- kvalita života MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- prospektivní studie MeSH
- remodelace komor * MeSH
- srdeční komory diagnostické zobrazování patofyziologie chirurgie MeSH
- srdeční selhání etiologie patofyziologie chirurgie MeSH
- tepový objem fyziologie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
AIMS: Surgical ventricular reconstruction to remodel, reshape, and reduce ventricular volume is an effective therapy in selected patients with chronic heart failure (HF) of ischaemic aetiology. The BioVentrix Revivent TC System offers efficacy comparable to conventional surgical ventricular reconstruction and is less invasive utilizing micro-anchor pairs to exclude scarred myocardium on the beating heart. Here, we present 12-months follow-up data of an international multicenter study. METHODS AND RESULTS: Patients were considered eligible for the procedure when they presented with symptomatic HF [New York Heart Association (NYHA) class ≥II], left ventricular (LV) dilatation and dysfunction caused by myocardial infarction, and akinetic and/or dyskinetic transmural scarred myocardium located in the anteroseptal, anterolateral, and/or apical regions. A total of 89 patients were enrolled and 86 patients were successfully treated (97%). At 12 months, a significant improvement in LV ejection fraction (29 ± 8% vs. 34 ± 9%, P < 0.005) and a reduction of LV volumes was observed (LV end-systolic and end-diastolic volume index both decreased: 74 ± 28 mL/m2 vs. 54 ± 23 mL/m2 , P < 0.001; and 106 ± 33 mL/m2 vs. 80 ± 26 mL/m2 , respectively, P < 0.0001). Four patients (4.5%) died in hospital and survival at 12 months was 90.6%. At baseline, 59% of HF patients were in NYHA class III compared with 22% at 12-month follow-up. Improvements in quality of life measures (Minnesota Living with Heart Failure Questionnaire 39 vs. 26 points, P < 0.001) and 6-min walking test distance (363 m vs. 416 m, P = <0.001) were also significant. CONCLUSIONS: Treatment with the Revivent TC System in patients with symptomatic HF results in significant and sustained reduction of LV volumes and improvement of LV function, symptoms, and quality of life.
Anglia Ruskin University Chelmsford UK
BIH Center for Regenerative Therapies Charité Universitätsmedizin Berlin Berlin Germany
CardioVascular Center Frankfurt Frankfurt am Main Germany
Department of Cardiac Surgery Na Homolce Hospital Prague Czech Republic
Department of Cardiology Asklepios Klinik St Georg Hamburg Germany
Department of Cardiology Kings College Hospital London UK
Department of Cardiology Na Homolce Hospital Prague Czech Republic
Department of Cardiothoracic Surgery Drexel University College of Medicine Philadelphia PA USA
Department of Cardiothoracic Surgery St Antonius Hospital Nieuwegein The Netherlands
Department of Internal Medicine Cardiology Charité Campus Virchow Clinic Berlin Germany
Department of Internal Medicine Cardiology German Heart Center Berlin Berlin Germany
Division of Cardiology and Metabolism Department of Cardiology Charité Berlin Germany
DZHK Partner Site Berlin Germany
Intituto di Cardiologia Azienda Ospedaliero Universitaria di Bologna Bologna Italy
Zobrazit více v PubMed
Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol 2011;8:30-41.
Roth GA, Nguyen G, Forouzanfar MH, Mokdad AH, Naghavi M, Murray CJ. Estimates of global and regional premature cardiovascular mortality in 2025. Circulation 2015;132:1270-1282.
Buckberg G, Athanasuleas C, Conte J. Surgical ventricular restoration for the treatment of heart failure. Nat Rev Cardiol 2012;9:703-716.
Buckberg GD. Ventricular restoration - a surgical approach to reverse ventricular remodeling. Heart Fail Rev 2004;9:233-239.
Hamer AW, Takayama M, Abraham KA, Roche AH, Kerr AR, Williams BF, Ramage MC, White HD. End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. Circulation 1994;90:2899-2904.
Axelrad JE, Pinsino A, Trinh PN, Thanataveerat A, Brooks C, Demmer RT, Effner L, Parkis G, Cagliostro B, Han J, Garan AR, Topkara V, Takeda K, Takayama H, Naka Y, Ramirez I, Garcia-Carrasquillo R, Colombo PC, Gonda T, Yuzefpolskaya M. Limited usefulness of endoscopic evaluation in patients with continuous-flow left ventricular assist devices and gastrointestinal bleeding. J Heart Lung Transplant 2018;37:723-732.
Athanasuleas CL, Buckberg GD, Stanley AW, Siler W, Dor V, di Donato M, Menicanti L, Almeida de Oliveira S, Beyersdorf F, Kron IL, Suma H, Kouchoukos NT, Moore W, McCarthy P, Oz MC, Fontan F, Scott ML, Accola KA; RESTORE Group. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol 2004;44:1439-1445.
Di Donato M, Frigiola A, Benhamouda M, Menicanti L. Safety and efficacy of surgical ventricular restoration in unstable patients with recent anterior myocardial infarction. Circulation 2004;110 (11 Suppl 1):II169-II173.
Crespo-Leiro MG, Cuenca-Castillo JJ. Surgical treatment of heart failure: heart transplantation and ventricular restoration surgery. Eur Heart J Suppl 2006;8:E39-E42.
Athanasuleas CL, Stanley AW, Buckberg GD, Dor V, di Donato M, Siler W; RESTORE Group. Surgical anterior ventricular endocardial restoration (SAVER) for dilated ischemic cardiomyopathy. Semin Thorac Cardiovasc Surg 2001;13:448-458.
Michler RE, Rouleau JL, Al-Khalidi HR, Bonow RO, Pellikka PA, Pohost GM, Holly TA, Oh JK, Dagenais F, Milano C, Wrobel K, Pirk J, Ali IS, Jones RH, Velazquez EJ, Lee KL, Di Donato M; STICH Trial Investigators. Insights from the STICH trial: change in left ventricular size after coronary artery bypass grafting with and without surgical ventricular reconstruction. J Thorac Cardiovasc Surg 2013;146:1139-1145.
Wechsler AS, Sadowski J, Kapelak B, Bartus K, Kalinauskas G, Rucinskas K, Samalavicius R, Annest L. Durability of epicardial ventricular restoration without ventriculotomy. Eur J Cardiothorac Surg 2013;44:e189-e192.
Shoemaker MJ, Curtis AB, Vangsnes E, Dickinson MG. Clinically meaningful change estimates for the six-minute walk test and daily activity in individuals with chronic heart failure. Cardiopulm Phys Ther J 2013;24:21-29.
Gonzalez-Saenz de Tejada M, Bilbao A, Ansola L, Quirós R, García-Perez L, Navarro G, Escobar A. Responsiveness and minimal clinically important difference of the Minnesota Living with Heart Failure Questionnaire. Health Qual Life Outcomes 2019;17:36.
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Assocition (HFA) of the ESC. Eur J Heart Fail 2016;18:891-975.
Cooley DA. Endoaneurysmorrhaphy revisited. Tex Heart Inst J 1984;11:8-9.
Dor V. Left ventricular aneurysms: the endoventricular circular patch plasty. Semin Thorac Cardiovasc Surg 1997;9:123-130.
Athanasuleas CL, Buckberg GD, Stanley AW, Siler W, Dor V, DiDonato M, Menicanti L, de Oliveira SA, Beyersdorf F, Kron IL, Suma H, Kouchoukos NT, Moore W, McCarthy P, Oz MC, Fontan F, Scott ML, Accola KA; RESTORE Group. Surgical ventricular restoration: the RESTORE group experience. Heart Fail Rev 2004;9:287-297.
Broderick JP. The STICH trial: what does it tell us and where do we go from here? Stroke 2005;36:1619-1620.
Di Donato M, Castelvecchio S, Menicanti L. Surgical treatment of ischemic heart failure: the Dor procedure. Circ J 2009;73 Suppl. A:A1-A5.
Menicanti L, Castelvecchio S, Ranucci M, Frigiola A, Santambrogio C, de Vincentiis C, Brankovic J, di Donato M. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J Thorac Cardiovasc Surg 2007;134:433-441.
Hwang HY, Kim JS, Cho KR, Kim KB. Surgical anterior ventricular endocardial restoration performed with total arterial revascularization: serial 5-year follow-up. J Thorac Cardiovasc Surg 2014;148:529-535.
Castelvecchio S, Ranucci M, Bandera F, Baryshnikova E, Giacomazzi F, Menicanti L; Surgical and Clinical Outcome Research (SCORE) Group. The additional prognostic value of left atrial volume on the outcome of patients after surgical ventricular reconstruction. Ann Thorac Surg 2013;95:141-147.
Di Donato M, Castelvecchio S, Brankovic J, Santambrogio C, Montericcio V, Menicanti L. Effectiveness of surgical ventricular restoration in patients with dilated ischemic cardiomyopathy and unrepaired mild mitral regurgitation. J Thorac Cardiovasc Surg 2007;134:1548-1553.
O'Neill JO, Starling RC, McCarthy PM, Albert NM, Lytle BW, Navia J, Young JB, Smedira N. The impact of left ventricular reconstruction on survival in patients with ischemic cardiomyopathy. Eur J Cardiothorac Surg 2006;30:753-759.
Oh JK, Velazquez EJ, Menicanti L, Pohost GM, Bonow RO, Lin G, Hellkamp AS, Ferrazzi P, Wos S, Rao V, Berman D, Bochenek A, Cherniavsky A, Rogowski J, Rouleau JL, Lee KL; STICH Investigators. Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy. Eur Heart J 2013;34:39-47.
Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, Maehara A, Eitel I, Granger CB, Jenkins PL, Nichols M, Ben-Yehuda O. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J Am Coll Cardiol 2016;67:1674-1683.
Ahmad FA, Petrie MC, McMurray JJV, Lang NN. Personalized medicine and hospitalization for heart failure: if we understand it, we may be successful in treating it. Eur J Heart Fail 2019;21:699-702.
